Cargando…
Epidemiology and disease burden of sickle cell disease in France: A descriptive study based on a French nationwide claim database
CONTEXT: Sickle cell disease (SCD) is a severe hematological disorder. The most common acute complication of SCD is vaso-occlusive crisis (VOC), but SCD is a systemic disease potentially involving all organs. SCD prevalence estimates rely mostly on extrapolations from incidence-based newborn screeni...
Autores principales: | Leleu, Henri, Arlet, Jean Benoit, Habibi, Anoosha, Etienne-Julan, Maryse, Khellaf, Mehdi, Adjibi, Yolande, Pirenne, France, Pitel, Marine, Granghaud, Anna, Sinniah, Cynthia, De Montalembert, Mariane, Galacteros, Frédéric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270152/ https://www.ncbi.nlm.nih.gov/pubmed/34242255 http://dx.doi.org/10.1371/journal.pone.0253986 |
Ejemplares similares
-
Prevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon Généraliste des Bénéficiaires
por: Beillat, Maud, et al.
Publicado: (2023) -
Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal
por: Thein, Swee Lay, et al.
Publicado: (2020) -
First evidence of subclinical renal tubular injury during sickle-cell crisis
por: Audard, Vincent, et al.
Publicado: (2014) -
Transfusion‐related adverse events are decreased in pregnant women with sickle cell disease by a change in policy from systematic transfusion to prophylactic oxygen therapy at home: A retrospective survey by the international sickle cell disease observatory
por: Ribeil, Jean‐Antoine, et al.
Publicado: (2018) -
P-090: IS A DEDICATED MARKETING APPROVAL OF HYDROXYUREA IN SICKLE CELL DISEASE MAY INCREASE THE CLINICAL BENEFIT OF THE DRUG?
por: F., GALACTÉROS, et al.
Publicado: (2022)